Table of Contents

Executive Summary

1 Industry Overview of Cancer Biomarker

• 1.1 Definition of Cancer Biomarker
• 1.2 Cancer Biomarker Segment by Type
  • 1.2.1 Global Cancer Biomarker Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Protein Biomarker
  • 1.2.3 Genetic Biomarker
• 1.3 Cancer Biomarker Segment by Applications
  • 1.3.1 Global Cancer Biomarker Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Diagnostics
  • 1.3.3 Research
  • 1.3.4 Prognostics
  • 1.3.5 Risk Assessment
  • 1.3.6 Other Applications
• 1.4 Global Cancer Biomarker Overall Market
  • 1.4.1 Global Cancer Biomarker Revenue (2014-2025)
  • 1.4.2 Global Cancer Biomarker Production (2014-2025)
  • 1.4.3 North America Cancer Biomarker Status and Prospect (2014-2025)
  • 1.4.4 Europe Cancer Biomarker Status and Prospect (2014-2025)
  • 1.4.5 China Cancer Biomarker Status and Prospect (2014-2025)
  • 1.4.6 Japan Cancer Biomarker Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Cancer Biomarker Status and Prospect (2014-2025)
  • 1.4.8 India Cancer Biomarker Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Cancer Biomarker
• 2.3 Manufacturing Process Analysis of Cancer Biomarker
• 2.4 Industry Chain Structure of Cancer Biomarker

3 Development and Manufacturing Plants Analysis of Cancer Biomarker

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Cancer Biomarker Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Cancer Biomarker
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Cancer Biomarker Production and Capacity Analysis
• 4.2 Cancer Biomarker Revenue Analysis
• 4.3 Cancer Biomarker Price Analysis
• 4.4 Market Concentration Degree

5 Cancer Biomarker Regional Market Analysis

• 5.1 Cancer Biomarker Production by Regions
  • 5.1.1 Global Cancer Biomarker Production by Regions
  • 5.1.2 Global Cancer Biomarker Revenue by Regions
• 5.2 Cancer Biomarker Consumption by Regions
• 5.3 North America Cancer Biomarker Market Analysis
  • 5.3.1 North America Cancer Biomarker Production
  • 5.3.2 North America Cancer Biomarker Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Cancer Biomarker Import and Export
• 5.4 Europe Cancer Biomarker Market Analysis
  • 5.4.1 Europe Cancer Biomarker Production
  • 5.4.2 Europe Cancer Biomarker Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Cancer Biomarker Import and Export
• 5.5 China Cancer Biomarker Market Analysis
  • 5.5.1 China Cancer Biomarker Production
  • 5.5.2 China Cancer Biomarker Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Cancer Biomarker Import and Export
• 5.6 Japan Cancer Biomarker Market Analysis
  • 5.6.1 Japan Cancer Biomarker Production
  • 5.6.2 Japan Cancer Biomarker Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Cancer Biomarker Import and Export
• 5.7 Southeast Asia Cancer Biomarker Market Analysis
  • 5.7.1 Southeast Asia Cancer Biomarker Production
  • 5.7.2 Southeast Asia Cancer Biomarker Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Cancer Biomarker Import and Export
• 5.8 India Cancer Biomarker Market Analysis
  • 5.8.1 India Cancer Biomarker Production
  • 5.8.2 India Cancer Biomarker Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Cancer Biomarker Import and Export

6 Cancer Biomarker Segment Market Analysis (by Type)

• 6.1 Global Cancer Biomarker Production by Type
• 6.2 Global Cancer Biomarker Revenue by Type
• 6.3 Cancer Biomarker Price by Type

7 Cancer Biomarker Segment Market Analysis (by Application)

• 7.1 Global Cancer Biomarker Consumption by Application
• 7.2 Global Cancer Biomarker Consumption Market Share by Application (2014-2019)

8 Cancer Biomarker Major Manufacturers Analysis

• 8.1 Thermo Fisher Scientific
  • 8.1.1 Thermo Fisher Scientific Cancer Biomarker Production Sites and Area Served
  • 8.1.2 Thermo Fisher Scientific Product Introduction, Application and Specification
  • 8.1.3 Thermo Fisher Scientific Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bio-Rad Laboratories
  • 8.2.1 Bio-Rad Laboratories Cancer Biomarker Production Sites and Area Served
  • 8.2.2 Bio-Rad Laboratories Product Introduction, Application and Specification
  • 8.2.3 Bio-Rad Laboratories Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Roche Diagnostics
  • 8.3.1 Roche Diagnostics Cancer Biomarker Production Sites and Area Served
  • 8.3.2 Roche Diagnostics Product Introduction, Application and Specification
  • 8.3.3 Roche Diagnostics Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Qiagen
  • 8.4.1 Qiagen Cancer Biomarker Production Sites and Area Served
  • 8.4.2 Qiagen Product Introduction, Application and Specification
  • 8.4.3 Qiagen Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Illumina
  • 8.5.1 Illumina Cancer Biomarker Production Sites and Area Served
  • 8.5.2 Illumina Product Introduction, Application and Specification
  • 8.5.3 Illumina Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 GE Healthcare
  • 8.6.1 GE Healthcare Cancer Biomarker Production Sites and Area Served
  • 8.6.2 GE Healthcare Product Introduction, Application and Specification
  • 8.6.3 GE Healthcare Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Agilent Technologies
  • 8.7.1 Agilent Technologies Cancer Biomarker Production Sites and Area Served
  • 8.7.2 Agilent Technologies Product Introduction, Application and Specification
  • 8.7.3 Agilent Technologies Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Biomérieux SA
  • 8.8.1 Biomérieux SA Cancer Biomarker Production Sites and Area Served
  • 8.8.2 Biomérieux SA Product Introduction, Application and Specification
  • 8.8.3 Biomérieux SA Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Merck & Co.
  • 8.9.1 Merck & Co. Cancer Biomarker Production Sites and Area Served
  • 8.9.2 Merck & Co. Product Introduction, Application and Specification
  • 8.9.3 Merck & Co. Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Abbott Laboratories
  • 8.10.1 Abbott Laboratories Cancer Biomarker Production Sites and Area Served
  • 8.10.2 Abbott Laboratories Product Introduction, Application and Specification
  • 8.10.3 Abbott Laboratories Cancer Biomarker Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Becton, Dickinson and Company
• 8.12 Danaher Corporation
• 8.13 Myriad Genetics
• 8.14 Sysmex Corporation
• 8.15 Hologic
• 8.16 Quest Diagnostics

9 Development Trend of Analysis of Cancer Biomarker Market

• 9.1 Global Cancer Biomarker Market Trend Analysis
  • 9.1.1 Global Cancer Biomarker Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Cancer Biomarker Regional Market Trend
  • 9.2.1 North America Cancer Biomarker Forecast 2019-2025
  • 9.2.2 Europe Cancer Biomarker Forecast 2019-2025
  • 9.2.3 China Cancer Biomarker Forecast 2019-2025
  • 9.2.4 Japan Cancer Biomarker Forecast 2019-2025
  • 9.2.5 Southeast Asia Cancer Biomarker Forecast 2019-2025
  • 9.2.6 India Cancer Biomarker Forecast 2019-2025
• 9.3 Cancer Biomarker Market Trend (Product Type)
• 9.4 Cancer Biomarker Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Cancer Biomarker Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
In terms of applications, diagnostics accounted for major share of the global cancer biomarkers market in 2017.

The global Cancer Biomarker market was valued at 11600 million US$ in 2018 and will reach 29300 million US$ by the end of 2025, growing at a CAGR of 12.3% during 2019-2025.
This report focuses on Cancer Biomarker volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Biomarker market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Biomarker in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer Biomarker manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Protein Biomarker
Genetic Biomarker

Segment by Application
Diagnostics
Research
Prognostics
Risk Assessment
Other Applications